OS07.5 Interim analysis data from Phase 2 study on efficacy, safety & intratumoral pharmacokinetics of oral Selinexor (KPT-330) in patients with recurrent glioblastoma (GBM)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.